ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Activity
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

22 hedge funds and large institutions have $471K invested in Oncternal Therapeutics, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
-4
Holders Change %
-15.38%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VF
Virtu Financial
New York
$16K
2
TRCT
Tower Research Capital (TRC)
New York
$3.73K
3
UBS Group
UBS Group
Switzerland
$1.61K
4
Renaissance Technologies
Renaissance Technologies
New York
$23.6K
5
BlackRock
BlackRock
New York
$52.4K

Top Sellers

1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
$0
2
RB
Richmond Brothers
Michigan
$0
3
BJL
Brighton Jones LLC
Washington
$0
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$0
5
Millennium Management
Millennium Management
New York
$80.8K
Name Holding Trade Value Shares
Change 		Shares
Change %
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
– -$116K -15,206 Closed
US Bancorp
27
US Bancorp
Minnesota
– -$760 -100 Closed
Fidelity Investments
28
Fidelity Investments
Massachusetts
– -$547 -72 Closed
1
2